We are live on ! Find out more
O

OrbiMed Portfolio holdings

AUM $5.05B
1-Year Est. Return 125.28%
This Fund
S&P 500
This Quarter Est. Return
-12.52%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$9.5B
AUM Growth
-$1.54B
Cap. Flow
+$155M
Cap. Flow %
1.63%
Top 10 Hldgs %
41.52%
Holding
149
New
17
Increased
43
Reduced
27
Closed
8

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$108M
2
CRVS icon
Corvus Pharmaceuticals
CRVS
+$75.4M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$71.1M
4
LLY icon
Eli Lilly
LLY
+$70.2M
5
UNH icon
UnitedHealth
UNH
+$67.9M

Top Sells

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$205M
2
VTRS icon
Viatris
VTRS
+$149M
3
AFFX
Affymetrix Inc
AFFX
+$75.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$59.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 89.92%
2 Financials 0.22%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
126
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$1.54M 0.02%
+200,000
New +$1.46M
XTNT icon
127
Xtant Medical Holdings
XTNT
$59.1M
$1.29M 0.01%
39,620
– –
FATE icon
128
Fate Therapeutics
FATE
$267M
$1.25M 0.01%
692,900
– –
PTX
129
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$1.13M 0.01%
107,300
– –
CGNT
130
DELISTED
Cogentix Medical, Inc.
CGNT
$1.09M 0.01%
990,745
– –
BLRX
131
BioLineRX
BLRX
$12.3M
$1.06M 0.01%
1,731
– –
QLTI
132
DELISTED
QLT Inc
QLTI
$995K 0.01%
500,000
– –
AMRN
133
Amarin Corp
AMRN
$300M
$536K 0.01%
17,500
– –
MNKD icon
134
PUT
MannKind Corp
MNKD
$1.21B
– –
-90,000
Closed -$653K
MOH icon
135
Molina Healthcare
MOH
$10.6B
– –
-568,850
Closed -$34.2M
OCUL icon
136
Ocular Therapeutix
OCUL
$1.83B
– –
-155,000
Closed -$1.45M
ALIM
137
CALL
DELISTED
Alimera Sciences
ALIM
– –
-13,333
Closed -$484K
KDNY
138
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-12,000
Closed -$1.69M
VTAE
139
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
– –
-487,400
Closed -$8.82M
AFFX
140
DELISTED
Affymetrix Inc
AFFX
– –
-7,511,000
Closed -$75.8M
HNT
141
DELISTED
HEALTH NET INC
HNT
– –
-2,988,800
Closed -$205M
2 3 4 5
6

Similar funds

HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.02B AUM 21.87% 1-Year Est. Return
LFG
Lazard Frères Gestion Paris, France $5.07B AUM 20.66% 1-Year Est. Return
JIM
Jensen Investment Management Lake Oswego, Oregon $5.07B AUM 4.98% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return

OrbiMed's Q1 2016 Portfolio in Review

As of Q1 2016, OrbiMed held 149 positions worth $9.5B, down 14% from $11B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

OrbiMed's Q1 2016 filing shows 17 new, 43 increased, 27 reduced and 8 closed positions. Its largest new stake was Corvus Pharmaceuticals: 5,258,450 shares worth $76.2M. The largest sale was HEALTH NET INC, an estimated $205M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier, followed by Financials and Technology.

  • OrbiMed's largest Q1 2016 buy was Corvus Pharmaceuticals: 5,258,450 shares worth $76.2M.
  • OrbiMed added most to Vertex Pharmaceuticals in Q1 2016, an estimated $108M increase.
  • OrbiMed's biggest Q1 2016 reduction was Viatris, cutting an estimated $149M.
  • OrbiMed fully exited HEALTH NET INC in Q1 2016, selling an estimated $205M.
  • OrbiMed's ten largest holdings make up 42% of its $9.5B portfolio in Q1 2016.
  • OrbiMed opened 17 new positions and closed 8 in Q1 2016.
  • OrbiMed's portfolio value fell 14% quarter-over-quarter to $9.5B.

Based on OrbiMed's 13F filing for Q1 2016, filed 16 May 2016.